BioAge Labs director granted 22,000 stock options
BioAge Labs, Inc. director Vijay Satyanand Pande received a grant of stock options covering 22,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BioAge Labs, Inc. director Vijay Satyanand Pande received a grant of stock options covering 22,000 shares of common stock. The options have an exercise price of $15.48 per share and expire on June 9, 2036, bringing his directly held option position reported here to 22,000 shares. The entire award vests on the earlier of the next annual stockholder meeting or one year from the grant date, if he continues serving the company.
Insider Trade Summary
Grant/Award: 22,000 shares
Grant/Award
1 txn
Insider
Pande Vijay Satyanand
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 22,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 22,000 options (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 0 to 22,000 options (Direct)
Footnotes (1)
- F1. The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.
Key Figures
Options granted: 22,000 options
Exercise price: $15.48 per share
Expiration date: June 9, 2036
+2 more
5 metrics
Options granted
22,000 options
Stock Option (Right to Buy) grant on June 10, 2026
Exercise price
$15.48 per share
Option strike price for underlying common stock
Expiration date
June 9, 2036
Option term end for this award
Underlying shares
22,000 shares
Common stock underlying granted options
Post-grant derivative holdings
22,000 options
Total options directly held after this transaction
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 15.4800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The entire option award shall vest on the earlier of..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-09T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did BioAge Labs (BIOA) director Vijay Pande report on this Form 4?
Vijay Pande reported receiving a stock option grant for 22,000 shares of BioAge Labs common stock. The options are a compensation-related award, not an open-market purchase or sale of existing shares.
What is the exercise price of the BioAge Labs (BIOA) options granted to Vijay Pande?
The granted stock options have an exercise price of $15.48 per share. This means Pande can buy BioAge Labs common stock at $15.48 once the options vest and are exercised, regardless of the future market price.
When do Vijay Pande’s BioAge Labs (BIOA) stock options vest?
The entire option award vests on the earlier of the next annual meeting of BioAge Labs stockholders or the one-year anniversary of the grant date. Vesting requires Pande’s continued service to the company through the applicable vesting date.
When do the BioAge Labs (BIOA) options granted to Vijay Pande expire?
The stock options granted to Vijay Pande expire on June 9, 2036. After that expiration date, any unexercised options will lapse and can no longer be used to buy BioAge Labs common stock at the $15.48 exercise price.
How many BioAge Labs (BIOA) options does Vijay Pande hold after this grant?
Following this award, Vijay Pande is reported as directly holding 22,000 stock options. These options each relate to one share of BioAge Labs common stock, subject to vesting and exercisability conditions described in the Form 4 footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
